Oral News and Research

RSS

VOICE continues testing daily use of ARV Truvada among women in sub-Saharan Africa

VOICE, an HIV prevention trial that has been evaluating two antiretroviral (ARV)-based approaches for preventing the sexual transmission of HIV in women - daily use of one of two different ARV tablets or of a vaginal gel - has stopped testing the gel.

29 Nov 2011

Tenofovir gel no more effective than placebo gel in preventing HIV

An independent review of the VOICE study, funded by the National Institute of Allergy and Infectious Diseases (NIAID) and conducted by the Microbicide Trials Network, determined that tenofovir gel was no more effective than placebo gel in preventing HIV.

28 Nov 2011

FDA grants IND for AEZS-130 Phase 2A trial in cancer cachexia

Aeterna Zentaris Inc. today announced that the U.S. Food and Drug Administration has granted Jose M. Garcia, MD, PhD, Assistant Professor, Division of Diabetes Endocrinology and Metabolism, Departments of Medicine and Molecular and Cell Biology, Baylor College of Medicine and Michael I. DeBakey Veterans Administration Medical Center, in Houston Texas, an Investigational New Drug approval for the initiation of a Phase 2A trial to assess the safety and efficacy of repeated doses of the Company's ghrelin agonist, AEZS-130, in patients with cancer cachexia.

28 Nov 2011

Henry Schein launches new integrated comprehensive solution to treat sleep apnea

Henry Schein, Inc., the largest provider of health care products and services to office-based practitioners, today announced the launch of its Sleep Complete™ program, a new integrated comprehensive solution that provides all of the information and products necessary for the successful implementation of dental sleep medicine into the dental practice.

28 Nov 2011

Just a few drugs responsible for majority of emergency hospitalizations

Latest research shows that just a few drugs are responsible for a majority of the emergency hospitalizations for bad events related to medication use in older U.S. adults.

24 Nov 2011

Deadly outbreak of acute watery diarrhea spreads through Horn of Africa; Djibouti hit especially hard

"Recurring drought, insufficient hygiene and ongoing regional conflict are driving a deadly outbreak of acute watery diarrhea (AWD) across the Horn of Africa, the United Nations World Health Organization (WHO) reported" on Tuesday, the U.N. News Centre writes.

24 Nov 2011

University of Rochester receives U.S. patent for HPV vaccine research

The University of Rochester has been awarded a U.S. patent for research essential to both human papillomavirus vaccines on the market.

23 Nov 2011

Pediatricians warn about hazards of button batteries

With the increasing production of electronic products in the consumer market, more button batteries are found in the home setting. From remote controls and watches to musical greeting cards and toys, these small, shiny objects are the perfect size for a curious child to swallow or even push into their nasal cavity or ear canal. It is important for parents to be aware of the dangers that button batteries pose to young children and the damage that these batteries can cause.

23 Nov 2011

Insurers fear consequences of individual mandate being struck down

The Hill writes that letting the 2010 health law stand without the individual mandate is the worst possible outcome for insurers. Meanwhile, CQ looks into the Medicaid expansion issue and demands for Kagan and Thomas to recuse themselves.

23 Nov 2011

Oral antibiotics might treat Buruli ulcer

It might be possible to treat Buruli ulcer, a crippling and deforming disease, with only oral medicines, which would make treatment easier. And even the current treatment can in many cases be given in an outpatient regimen.

23 Nov 2011

Naltrexone for problem gamblers

According to new practice guidelines Australian doctors treating gambling addicts now can consider prescribing an anti-heroin drug, naltrexone, to help problem gamblers control their impulses. Australia has one of the world’s highest rates of problem gamblers, with about 2.1 per cent of Australians experiencing some form of gambling problem.

22 Nov 2011

Sore throat among young adults taking antibiotics for acne: Study

A new study reveals that young adults who take oral antibiotics for acne may be more likely to get sore throats. The reason behind this is unclear say researchers. However they add that long-term use of antibiotics might change the balance of bacteria in the throat. In principle, that could allow infection-causing strains to multiply.

22 Nov 2011

Supreme Court names lawyers to participate in health law case

The high court named two lawyers to argue specific elements of the health law case - both of which are related to the individual mandate. Meanwhile, Republicans step up questions on Justice Elena Kagan's level of involvement regarding the health law in her prior position when she was the Obama administration's solicitor general. In addition, Democrats continue to push on Justice Clarence Thomas' possible conflicts of interest.

22 Nov 2011

Oral delivery of PYY hormone can help obese people lose weight

Most people understand that serious weight loss requires changing attitudes toward what they eat and how often they exercise. But, what if the process could be aided by simply chewing a stick of gum after meals? That's the question a team of scientists, led by Syracuse University chemist Robert Doyle, is trying to answer. In a groundbreaking new study, Doyle's team demonstrated, for the first time, that a critical hormone that helps people feel "full" after eating can be delivered into the bloodstream orally.

22 Nov 2011

Despite market constraints, the drug market for key hospital-treated infections will increase: Report

Decision Resources finds that the drug market for key hospital-treated infections that are of high interest to drug developers—most notably nosocomial pneumonia, bloodstream infections, skin and skin structure/surgical site infections and urinary tract infections—will increase from $3.3 billion in 2010 to just over $4 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

21 Nov 2011

ADA Seal of Acceptance helps consumers make informed decisions about dental products

For more than 125 years, the American Dental Association (ADA) has been evaluating dental products for safety and effectiveness. The ADA Seal of Acceptance, which is a registered certification mark, is awarded after a product is tested and meets ADA guidelines and standards. The Pennsylvania Dental Association encourages you to shop wisely and purchase dental care products with the ADA Seal.

21 Nov 2011

PLoS ONE publishes study on darinaparsin, a multivalent chemotherapeutic

ZIOPHARM Oncology, Inc. announced today the publication of a darinaparsin (Zinapar or ZIO-101) study in the PLoS ONE, an international, peer-reviewed, open-access, online publication of the Public Library of Science.

21 Nov 2011

Consistent data from three studies support plans for rindopepimut with ACT IV Phase 3 study

Celldex Therapeutics, Inc. today announced the presentation of mature overall survival (OS) data for ACT III, a multi-center, single arm, Phase 2 clinical trial of rindopepimut (CDX-110) in patients with newly diagnosed EGFRvIII-positive glioblastoma (GB).

21 Nov 2011

Clinical value of OrSense NBM 200 non-invasive Hb monitor for maternal health to be presented at 4th COGI

OrSense Ltd., announced today that two oral presentations on the clinical value of its NBM 200 non-invasive hemoglobin (Hb) monitor for maternal health and anemia monitoring prior, during and post delivery of pregnant women will be presented at the 4th Asia Pacific Congress on Controversies in Obstetrics Gynecology and Infertility (COGI).

21 Nov 2011

Gilead enters agreement for Pharmasset acquisition

Gilead Sciences, Inc. and Pharmasset, Inc. announced today that the companies have signed a definitive agreement under which Gilead will acquire Pharmasset for $137 per share in cash.

21 Nov 2011

Oral News and Research

VOICE continues testing daily use of ARV Truvada among women in sub-Saharan Africa

Tenofovir gel no more effective than placebo gel in preventing HIV

FDA grants IND for AEZS-130 Phase 2A trial in cancer cachexia

Henry Schein launches new integrated comprehensive solution to treat sleep apnea

Just a few drugs responsible for majority of emergency hospitalizations

Deadly outbreak of acute watery diarrhea spreads through Horn of Africa; Djibouti hit especially hard

University of Rochester receives U.S. patent for HPV vaccine research

Pediatricians warn about hazards of button batteries

Insurers fear consequences of individual mandate being struck down

Oral antibiotics might treat Buruli ulcer

Naltrexone for problem gamblers

Sore throat among young adults taking antibiotics for acne: Study

Supreme Court names lawyers to participate in health law case

Oral delivery of PYY hormone can help obese people lose weight

Despite market constraints, the drug market for key hospital-treated infections will increase: Report

ADA Seal of Acceptance helps consumers make informed decisions about dental products

PLoS ONE publishes study on darinaparsin, a multivalent chemotherapeutic

Consistent data from three studies support plans for rindopepimut with ACT IV Phase 3 study

Clinical value of OrSense NBM 200 non-invasive Hb monitor for maternal health to be presented at 4th COGI

Gilead enters agreement for Pharmasset acquisition

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News